论文信息 - Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States - 字舞流文

Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States

M. Exline | Akram Khan | W. Self | A. Ginde | A. Monto | T. Rice | C. Lindsell | D. Hager | N. Shapiro | M. Gong | Yuwei Zhu | I. Jones | N. Mohr | K. Hart | K. Gibbs | A. Lauring | E. Martin | J. Chappell | Carlos G. Grijalva | M. Gaglani | N. Halasa | D. Douin | J. Casey | J. Steingrub | Steven Y. Chang | M. Tenforde | S. Ghamande | J. Rhoads | H. Babcock | M. Prekker | Jennie H. Kwon | I. Peltan | William B. Stubblefield | A. Mohamed | Nida Qadir | H. Erickson | H. Keipp Talbot | L. Busse | D. Files | A. Zepeski | Nathaniel M. Lewis | Vasisht Srinivasan | M. Patel | A. Shehu | C. T. ten Lohuis | C. Rivas | K. Adams | Jennifer G. Wilson | N. Johnson | Christopher Mallow | A. Baughman | K. Womack | A. J. Gordon | Tresa A McNeal | Amuel M Brown | Bhijit Duggal